Prostate Cancer - Results from #40

Bayer to Unveil Latest NUBEQA® (darolutamide) Data and Prostate Cancer Research at American Urological Association (AUA) 2025 Annual Meeting (2) April 16, 2025

Clinical Outcomes and Genomic Alterations in Gleason Score 10 Prostate Cancer. April 16, 2025

Analytical Validation of MyProstateScore 2.0. April 16, 2025

Adverse In-Hospital Outcomes Following Robot-Assisted vs. Open Radical Prostatectomy in Quadragenarians. April 16, 2025

Single-Dose Radiation Therapy for Localized Prostate Cancer: Where Does the Evidence Lead? April 16, 2025

Developing a Predictive Model for Significant Prostate Cancer Detection in Prostatic Biopsies from Seven Clinical Variables: Is Machine Learning Superior to Logistic Regression? April 16, 2025

SECuRE Trial Update: First Patient Treated in the Phase II Cohort Expansion April 15, 2025

Predictors of bladder spasm during catheter-indwelling in discharged patients after robot-assisted laparoscopic radical prostatectomy. April 15, 2025

Do differences in secondary treatment explain mortality impact of prostate cancer screening? - A randomized screening trial. April 15, 2025

Long-term Oncological Outcomes of Partial Gland Cryoablation of Localized Prostate Cancer with Median Follow-up of 7 Years: A Single-institution Experience. April 15, 2025

Long-term outcomes of active surveillance for Grade Group 1 prostate cancer and the impact of the use of MRI on overtreatment. April 15, 2025

Reprogramming of Androgen Receptor Activity in Castration-resistant Prostate Cancer is Shaped by Truncated Variants. April 15, 2025

An Online Treatment Decision Aid for Men with Low-risk Prostate Cancer Eligible for Active Surveillance and Their Partners Increases the Uptake of Active Surveillance: The Navigate Randomised Controlled Trial. April 15, 2025

External Validation of an Artificial Intelligence Algorithm Using Biparametric MRI and Its Simulated Integration with Conventional PI-RADS for Prostate Cancer Detection. April 15, 2025

Visceral metastases, platelet dynamics, and PSA decline: from biomarkers to better outcomes in [177Lu]Lu‑PSMA‑617 therapy in metastatic castration-resistant prostate cancer. April 14, 2025

Impact of ISUP grade group on cancer-specific mortality in radical prostatectomy-treated prostate cancer patients with organ-confined disease. April 14, 2025

Outcomes of Salvage Robotic-assisted Radical Prostatectomy: High-volume Multicentric Data from the European Association of Urology Robotic Urology Section Scientific Working Group. April 14, 2025

Stage IV Prostate Cancer Presenting With a Low Prostate-Specific Antigen Level: A Case Report. April 14, 2025

Comparative adverse event profiles of triplet therapy versus docetaxel-based therapy in patients with metastatic prostate cancer: a multicenter retrospective study. April 14, 2025

A comparison of surgical outcomes between outpatient and inpatient robot-assisted radical prostatectomy: A systematic review and meta-analysis. April 14, 2025

Page 3 of 1473